高级检索

    肺功能指标检测在老年慢性阻塞性肺疾病和冠心病中的鉴别诊断价值

    The value of pulmonary function test in the diagnosis and differential diagnosis of chronic obstructive pulmonary disease and coronary heart disease in the elderly

    • 摘要: 目的 研究肺功能指标检测在老年慢性阻塞性肺疾病(COPD)和冠心病中的诊断及鉴别诊断价值。方法 选取新疆维吾尔自治区人民医院2015年3月—2017年3月收治的CODP和冠心病确诊患者各60例,分别作为COPD组和冠心病组,同期选取60例健康体检者作为对照组。采用Masterscreen PFT肺功能仪,对所有研究对象进行常规肺通气、肺弥散功能以及肺容量测定。结果 COPD组和冠心病组肺活量(VC)、用力肺活量(FVC)、第1秒用力呼气容积(FEV1)、第1秒用力呼气容积占用力肺活量比值(FEV1/FVC)、呼气峰值流速(PEF)、肺一氧化碳弥散量(DLCO)、肺一氧化碳弥散量与肺泡通气量比值(DLCO/VA)水平均低于对照组,差异有统计学意义(P<0.01),且COPD组均低于冠心病组,差异有统计学意义(P<0.01);COPD组和冠心病组的肺功能残气量(FRC)、肺残气量(RV)及RV/肺总量(TLC)水平均高于对照组,差异有统计学意义(P<0.01),且COPD组均高于冠心病组,差异有统计学意义(P<0.01)。结论 检测肺功能指标能够有效诊断及鉴别老年COPD和冠心病,对早期诊断及治疗具有重要的指导作用,值得临床推广。

       

      Abstract: Objective To investigate the value of diagnosis and differential diagnosis of pulmonary function indexes in the elderly with chronic obstructive pulmonary disease (COPD) and the elderly with coronary heart disease (CHD). Methods from March 2015 to March 2017, 60 patients with CODP and 60 patients with CHD were selected as COPD group and CHD group respectively, and 60 healthy subjects were selected as control group. Using Masterscreen PFT pulmonary function instrument, the routine pulmonary ventilation, pulmonary diffusion function and pulmonary volume were measured in all subjects. Results levels of vital capacity (VC), forced vital capacity (FVC), forced expiratory volume in one second (FEV1), FEV1/FVC, peak expiratory flow (PEF), diffusion capacity of the lung for carbon monoxide (DLCO) and DLCO/alveolar volume (DLCO/VA) in COPD group and CHD group were significantly lower than those in the control group (P<0.01). The levels offunctional residual capacity (FRC), residual volume (RV) and RV/total lung capacity (RV/TLC) in COPD group and CHD group were significantly higher than those in the control group (P<0.01), and COPD group were significantly higher than those in CHD group (P<0.01). Conclusions The detection of pulmonary function index can effectively diagnose and differentiate COPD and CHD in the elderly, which has an important guiding role in early diagnosis and treatment of COPD and CHD, and is worthy of clinical promotion.

       

    /

    返回文章
    返回